Skip to main content

Advertisement

SpringerLink
Log in

Update on mild cognitive impairment

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Mild cognitive impairment (MCI) refers to persons whose memory or other cognitive abilities are not normal, but who do not have clinically diagnosed dementia. MCI has received considerable attention in the medical literature over the past few years. There were 63 original reports in the English language literature with the term "mild cognitive impairment" in the title in 2001 and 2002, in contrast to only 26 articles in the prior decade. Although criteria for MCI are not a matter of secure agreement, a consensus is emerging that MCI is common, is associated with significant mortality and morbidity, particularly the development of AD, and is due, in large part, to the same pathologic processes responsible for Alzheimer’s disease (AD). Current research efforts are geared towards understanding factors that contribute to the development of dementia among persons with MCI and towards intervention studies aimed at preventing the development of dementia among persons with MCI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Kral VA: Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962, 86:257–260.

    PubMed  CAS  Google Scholar 

  2. Crook T, Bartus RT, Ferris SH, et al.: Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Dev Neuropsychol 1986, 2:261–276.

    Article  Google Scholar 

  3. Jonker C, Hoyer C: The Amstel project: design and first findings. The course of mild cognitive impairment of the aged, a longitudinal 4-year study. Psychiatry J Univ Ott 1990, 15:207–211.

    CAS  Google Scholar 

  4. Flicker C, Ferris SH, Reisberg B: Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991, 41:1006–1009.

    PubMed  CAS  Google Scholar 

  5. Petersen RC, Doody R, Kurz A, et al.: Current concepts in mild cognitive impairment. Arch Neurol 2001, 58:1985–1992. Report of an international meeting on current Concepts in Mild Cognitive Impairment held in Chicago in June of 1999. Comprehensive review of earlier literature.

    Article  PubMed  CAS  Google Scholar 

  6. Frisoni GB, Galluzzi S, Bresciani L, et al.: Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 2002, 249:1423–1432.

    Article  PubMed  Google Scholar 

  7. Schneider JA, Wilson RS, Cochran EJ, et al.: Relation of cerebral infarctions to dementia and cognitive function in older person. Neurology 2003, 60:1082–1089.

    Article  PubMed  CAS  Google Scholar 

  8. Bennett DA, Wilson RS, Schneider JA, et al.: Natural history of mild cognitive impairment in older persons. Neurology 2002, 59:198–205. Longitudinal study compares risk of death, risk of AD, and change in global cognition and five specific cognitive abilities among more than 200 persons with MCI with nearly 600 persons without cognitive impairment. MCI is associated with nearly twofold greater risk of death, more than threefold greater risk of AD, and greater rate of decline in most, but not all, cognitive abilities.

    PubMed  CAS  Google Scholar 

  9. Griffith HR, Belue K, Sicola A, et al.: Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003, 60:449–457.

    PubMed  CAS  Google Scholar 

  10. Meyer J, Xu G, Thornby J, et al.: Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci 2002, 201:19–25.

    Article  PubMed  Google Scholar 

  11. Mapstone M, Steffenella TM, Duffy CJ: A visuospatial variant of mild cognitive impairment: Getting lost between aging and AD. Neurology 2003, 60:802–808.

    Article  PubMed  Google Scholar 

  12. Storandt M, Grant EA, Miller JP, Morris JC: Rates of progression in mild cognitive impairment and early Alzheimer’s disease. Neurology 2002, 59:1034–1041. Longitudinal study demonstrates that "incipient dementia" is associated with risk of institutionalization and death, in addition to change in cognitive function.

    PubMed  Google Scholar 

  13. Wilson RS, Beckett LA, Barnes LL, et al.: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002, 17:179–193.

    Article  PubMed  Google Scholar 

  14. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001, 56:37–42.

    PubMed  CAS  Google Scholar 

  15. Darby D, Maruff P, Collie A, et al.: Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology 2002, 59:1042–1046.

    Article  PubMed  CAS  Google Scholar 

  16. Larrieu S, Letenneur L, Orgogozo JM, et al.: Incidence and outcome of mild cognitive impairment in a populationbased prospective cohort. Neurology 2002, 59:1594–1599.

    PubMed  CAS  Google Scholar 

  17. Unverzagt FW, Gao S, Baiyewu O, et al.: Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001, 57:1655–1662.

    PubMed  CAS  Google Scholar 

  18. Hanninen T, Hallikainen M, Tuomainen S, et al.: Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002, 106:148–154.

    Article  PubMed  CAS  Google Scholar 

  19. Artero S, Touchon J, Ritchie K: Disability and mild cognitive impairment: a longitudinal population-based study. Int J Geriatr Psychiatry 2001, 16:1092–1097.

    Article  PubMed  CAS  Google Scholar 

  20. Lyketsos CG, Lopez O, Jones B, et al.: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002, 288:1475–1483. Larger, community-based study reports that about 40% of persons with MCI exhibit neuropsychiatric features, including depression, apathy, and irritability.

    Article  PubMed  Google Scholar 

  21. DeCarli C, Miller BL, Swan GE, et al.: Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001, 58:643–647.

    Article  PubMed  CAS  Google Scholar 

  22. Bennett DA, Wilson RS, Schneider JA, et al.: Apolipoprotein E4 allele, Alzheimer’s disease pathology, and the clinical expression of Alzheimer’s disease. Neurology 2003, 60:246–252.

    PubMed  CAS  Google Scholar 

  23. DeKosky ST, Ikonomovic M, Styren S, et al.: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002, 51:145–155. Reports that choline acetyltransferase activity is maintained in persons with MCI despite the loss of cholinergic basal forebrain neurons. This finding suggests that this system is upregulated. Data are being scrutinized to determine their importance regarding the use of cholinesterase inhibitor therapy for MCI.

    Article  PubMed  CAS  Google Scholar 

  24. Mufson EJ, Chen EY, Cochran EJ, et al.: Entorhinal cortex b-amyloid load in individuals with mild cognitive impairment. Exp Neurol 1999, 158:469–490.

    Article  PubMed  CAS  Google Scholar 

  25. Mitchell TW, Mufson EJ, Schneider JA, et al.: Parahippocampal tau pathology in healthy aging, mild cognitive impairment and early Alzheimer’s disease. Ann Neurol 2002, 51:182–189. Demonstrates that the density of tau-positive neurofibrillary tangles in the mesial temporal lobe in MCI is intermediate to that of AD and those without cognitive impairment.

    Article  PubMed  Google Scholar 

  26. Ghoshal N, Garcia-Sierra F, Wuu J, et al.: Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer’s disease. Exp Neurol 2002, 177:475–493.

    Article  PubMed  CAS  Google Scholar 

  27. Kordower JH, Chu Y, Stebbins GT, et al.: Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001, 49:202–213.

    Article  PubMed  CAS  Google Scholar 

  28. Morris JC, Storandt M, Miller JP, et al.: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001, 58:397–405.

    Article  PubMed  CAS  Google Scholar 

  29. Mufson EJ, Ma SY, Cochran EJ, et al.: Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer’s disease. J Comp Neurol 2000, 427:19–30.

    Article  PubMed  CAS  Google Scholar 

  30. Mufson EJ, Ma SY, Dills J, et al.: Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer’s disease. J Comp Neurol 2002, 443:136–153.

    Article  PubMed  CAS  Google Scholar 

  31. Chu YP, Cochran EJ, Bennett DA, et al.: Down regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer’s disease. J Comp Neurol 2001, 437:296–307.

    Article  PubMed  CAS  Google Scholar 

  32. Ikonomovic MD, Mufson EJ, Wuu J, et al.: Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer’s neuropathology. J Alzheimers Dis 2003, 5:39–48.

    PubMed  CAS  Google Scholar 

  33. Mufson EJ, Ikonomovic MD, Styren SD, et al.: Preservation of brain nerve growth factor in the elderly with mild cognitive impairment. Arch Neurol 2003, in press.

  34. Dickerson BC, Goncharova I, Sullivan MP, et al.: MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease. Neurobiol Aging 2001, 22:747–754.

    Article  PubMed  CAS  Google Scholar 

  35. Du AT, Schuff N, Amend D, et al.: Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2001, 71:441–447.

    Article  PubMed  CAS  Google Scholar 

  36. Kabani NJ, Sled JG, Chertkow H: Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer’s type. Neuroimage 2002, 15:604–610.

    Article  PubMed  Google Scholar 

  37. Van Der Flier WM, Van Den Heuvel DM, Weverling-Rijnsburger AW, et al.: Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002, 59:874–879.

    Article  Google Scholar 

  38. Padovani A, Borroni B, Colciaghi F, et al.: Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 2002, 59:71–75.

    Article  PubMed  Google Scholar 

  39. Pratico D, Clark CM, Liun F, et al.: Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 2002, 59:972–997.

    Article  PubMed  Google Scholar 

  40. Tabert MH, Albert SM, Borukhova-Milov L, et al.: Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002, 58:758–764.

    PubMed  CAS  Google Scholar 

  41. Devanand DP, Michaels-Marston KS, Liu X, et al.: Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 2000, 157:1399–1405.

    Article  PubMed  CAS  Google Scholar 

  42. Jack CR Jr, Petersen RC, Xu YC, et al.: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52:1397–1403.

    PubMed  Google Scholar 

  43. Arnaiz E, Jelic V, Almkvist O, et al.: Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001, 12:851–855.

    Article  PubMed  CAS  Google Scholar 

  44. Petersen RC, Smith GE, Ivnik RJ, et al.: Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 1995, 273:1274–1278.

    Article  PubMed  CAS  Google Scholar 

  45. Riemenschneider M, Lautenschlager N, Wagenpfeil S, et al.:Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002, 59:1729–1734.

    Article  PubMed  CAS  Google Scholar 

  46. de Leon MJ, Segal S, Tarshish CY, et al.: Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett 2002, 333:183–186.

    Article  PubMed  Google Scholar 

  47. Okamura N, Arai H, Maruyama M, et al.: Combined analysis of CSF tau levels and [(123)I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer’s disease. Am J Psychiatry 2002, 159:474–476.

    Article  PubMed  Google Scholar 

  48. Petersen RC, Stevens JC, Ganguli M, et al.: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1133–1142. Recommends that persons with MCI be identified and followed with cognitive screening tests for the development of dementia. Other clinical recommendations are also provided. None of the recommendations reach the status of standard of care.

    PubMed  CAS  Google Scholar 

  49. Doody RS, Stevens JC, Beck C, et al.: Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1154–1166. Noteworthy for stating that there is no evidence that current treatments for AD are of benefit for persons with MCI.

    PubMed  CAS  Google Scholar 

  50. Rapp S, Brenes G, Marsh AP: Memory enhancement training for older adults with mild cognitive impairment: a preliminary study. Aging Ment Health 2002, 6:5–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rush Alzheimer’s Disease Center, Rush Presbyterian-St. Luke’s Medical Center, 1645 West Jackson Boulevard, Suite 675, 60612, Chicago, IL, USA

    David A. Bennett MD

Authors
  1. David A. Bennett MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bennett, D.A. Update on mild cognitive impairment. Curr Neurol Neurosci Rep 3, 379–384 (2003). https://doi.org/10.1007/s11910-003-0020-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-003-0020-2

Keywords

Search

Navigation